Zhejiang Kanova Biopharmaceutical Co., LTD
Zhejiang Kanova Biopharmaceutical Co., LTD
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Bridging Study of XKH001 in Healthy Adult Caucasian Participants | Healthy Adult | Not yet recruiting | Phase 1 | 2026-08-11 | NCT07757659 | |
| Phase II Clinical Study to Evaluate the Efficacy and Safety of XKH001 Injection | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorder | Not yet recruiting | Phase 2 | 2026-04-09 | NCT07519499 | |
| Evaluate the Efficacy and Safety of XKH001 Injection in Patients With Moderate-to-Severe Atopic Dermatitis | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Not yet recruiting | Phase 2 | 2025-07-08 | NCT07054736 |